Lv11
40 积分 2025-10-07 加入
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
26分钟前
已完结
TIME for Endometrial Cancer: Advancements and Challenges in Therapeutic Targets for the Endometrial Cancer Tumor Immune Microenvironment
13天前
已完结
Advances in the management of endometrial cancer
20天前
已完结
Tumor immunology and immunotherapy for endometrial cancer
21天前
已完结
The role and participation of immune cells in the endometrial tumor microenvironment
21天前
已完结
Tumor immunology and immunotherapy for endometrial cancer
22天前
已完结
Immune evasion in endometrial cancer: Unraveling the latest mechanisms and future directions
22天前
已完结
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
28天前
已完结
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice
29天前
已完结
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
1个月前
已完结
皖公网安备34019202002308
